Citizens reitera calificación de acciones de Acrivon Therapeutics por avances en ensayo de cáncer endometrial
Acrivon Therapeutics, Inc. (ACRV) Presents at TD Cowen 46th Annual Health Care Conference - Slideshow (NASDAQ:ACRV) 2026-03-04